Quality of life in multiple sclerosis. Measures, relevance, problems, and perspectives;Lebensqualität bei multipler sklerose. Messinstrumente, bedeutung, probleme und perspektiven

Nervenarzt

Volumn 76, Issue 2, 2005, Pages 154-169

  Pollmann W ^a   Busch, C ^a   Voltz, R ^b  

^a Marianne Strauss Hospital   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Influencing factors; Measuring instruments; Multiple sclerosis; Quality of life; Test procedures

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE; METHYLPREDNISOLONE;

COGNITIVE DEFECT; DECISION MAKING; DEPRESSION; FATIGUE; FUNCTIONAL ASSESSMENT; HUMAN; IMMUNOTHERAPY; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; PALLIATIVE THERAPY; PATIENT CARE; REVIEW; SHORT FORM 36;

COGNITION DISORDERS; HEALTH STATUS INDICATORS; HUMANS; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE;

EID: 14544301020     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1790-8     Document Type: Review

References (114)

1. Amato MP, Ponziani G, Rossi F et al. (2001) Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 7(5):340-344
2. Andresen EM, Vahle VJ, Lollar D (2001) Proxy reliability: health-related quality of life (HRQoL) measures for people with disability. Qual Life Res 10(7):609-619
3. Arnoldus JH, Killestein J, Pfennings LE et al. (2000) Quality of life during the first 6 months of interferon-beta treatment in patients with MS. Mult Scler 6(5):338-342
4. Aronson KJ (1997) Quality of life among persons with multiple sclerosis and their caregivers. Neurology 48(1):74-80
5. Benito-Leon J, Morales JM, Rivera-Navarro J (2002) Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 9(5):497-502
6. Ben-Zacharia AB, Lublin FD (2001) Palliative care in patients with multiple sclerosis. Neurol Clin 19(4):801-827
7. Berk C, Carr J, Sinden M et al. (2002) Thalamic deep brain stimulation for the treatment of tremor due to multiple sclerosis: a prospective study of tremor and quality of life. J Neurosurg 97(4):815-820
8. Bethoux F, Miller DM, Kinkel RP (2001) Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life. Mult Scler 7(2):137-142
9. Bowen JD, Maravilla K, Margolin SB (2003) Open-label study of pirfenidone in patients with progressive forms of multiple sclerosis. Mult Scler 9:280-283
10. Brunet DG, Hopman WM, Singer MA et al. (1996) Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci 23(2):99-103
11. Bullinger M, Kirchberger I (1998) Der SF-36 Fragebogen zum Gesundheitszustand. Hogrefe, Göttingen.
12. Caine ED, Schwid RS (2002) Multiple sclerosis, depression, and the risk of suicide. Neurology 59:662-663
13. Canadian Burden of Illness study group (1998) Burden of illness of multiple sclerosis: Part II: Quality of life. Can J Neurol Sci 25(1):31-38
14. Cella DF, Dineen K, Arnason B et al. (1996) Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 47(1):129-139
15. Cutajar R, Ferriani E, Scandellari C et al. (2000) Cognitive function and quality of life in multiple sclerosis patients. J Neurovirol 6(Suppl 2):S186-5190
16. Devins GM, Edworthy SM, Seland TP et al. (1993) Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis 181(6):377-381
17. Dorman PJ, Slattery J, Farrell B et al. (1997) A randomised comparison of the EuroQoL and Short Form-36 after stroke. BMJ 315:461
18. Egner A, Phillips VL, Vora R et al. (2003) Depression, fatigue, and health-related quality of life among people with advanced multiple sclerosis: results from an exploratory telerehabilitation study. NeuroRehabilitation 18(2):125-133
19. Fabio RR ChoiT, Soderberg J et al. (1997) Health-related quality of life for patients with progressive multiple sclerosis: influence of rehabilitation. Phys Ther 77(12):1704-1716
20. Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674-678
21. Fischer JS, LaRocca NG, Miller DM et al. (1999) Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler 5(4):251-259
22. Flachenecker P, Rieckmann P (2003) Early intervention in multiple sclerosis: better outcomes for patients and society? Drugs 63(15):1525-1533
23. Ford HL, Gerry E, Johnson MH et al. (2001) Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 23(12)516-521
24. Freeman JA, Langdon DW, Hobart JC et al. (1999) Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 52(1)50-56
25. Freeman JA, Hobart JC, Thompson AJ (2001) Does adding MS-specific items to a generic measure (the SF-36) improve measurement? Neurology 57(1):68-74
26. Freeman JA, Thompson AJ, Fitzpatrick R et al. (2001) Interferon-β1b in the treatment of secondary progressive MS: impact on quality of life. Neurology 57(10):1870-1875
27. Frühwald S, Löffler-Stastka H, Eher R et al. (2001) Zusammenhänge zwischen Depression, Angst und Lebensqualität bei MultiplerSklerose. Wien Klin Wochenschr 113(9):333-338
28. Gianino JM, York MM, Paice JA et al. (1998) Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 30(1):47-54
29. Gold SM, Heesen C, Schulz H et al. (2001) Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler 7(2):119-130
30. Gold SM, Schulz H, Mönch A et al. (2003) Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 9:404-410
31. Gulick EE (1997) Correlates of quality of life among persons with multiple sclerosis. Nurs Res 46(6):305-311
32. Haupts M, Elias G, Hardt C et al. (2003) Lebensqualität bei Patienten mit schubförmiger MS in Deutschland. Nervenarzt 74:144-150
33. Haupts MR, Hardt C, Pöhlau D et al. (2001) Quality of life as a predictor for change in disability in MS. Neurology 56(9):1250
34. Henriksson F, Fredrikson S, Masterman T et al. (2001) Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol 8(1):27-35
35. Hermann BP, Vickrey B, Hays RD et al. (1996) A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 25(2):113-118
36. Hickey AM, Bury G, O'Boyle CA et al. (1996) A new short-form individual quality of life measure (SEI-QoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 313:29-33
37. Hooper J, Whittle IR (2003) Costs of thalamic deep brain stimulation for movement disorders in patients with multiple sclerosis. Br J Neurosurg 17(1):40-45
38. Janardhan V, Bakshi R (2000) Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol 57(10):1485-1491
39. Janardhan V, Bakshi R (2002) Quality of life in patients with multiple sclerosis. The impact of fatigue and depression. J Neurol Sci 205(1)51-58
40. Janssens AC, Doom PA, Boer JB et al. (2003) Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 108(6):389-395
41. Janssens ACJW, van Doom PA, de Boer JB et al. (2003) Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 9:397-403
42. Jonsson A, Dock J, Ravnborg MH (1996) Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand 93(4):229-235
43. Kenealy PM, Beaumont GJ, Lintern T et al. (2000) Autobiographical memory, depression and quality of life in multiple sclerosis. J Clin Exp Neuropsychol 22(1):125-131
44. Kirchberger I (2000) Der SF-36-Fragebogen zum Gesundheitszustand: Anwendung, Auswertung und Interpretation, Kapitel 11-2. In: Ravens-Sieberer U, Cieza A (Hrsg) Lebensqualität und Gesundheitsökonomie in der Medizin. Ecomed, Landsberg, pp 73-85
45. Kobelt G, Lindgren P, Smala A et al. (2001) Kosten und Lebensqualität bei Multipler Sklerose. HEPAC 2:60-68
46. Kohlmann T (2000) Das Nottingham Health Profile und das Sickness Impact Profile, Kapitel 11-3. In: Ravens-Sieberer U, Cieza A (Hrsg) Lebensqualität und Gesundheitsökonomie in der Medizin. Ecomed, Landsberg, pp 86-97. Original: Bergner M, Bobbit RA, Carter WB, et al. (1981) The sickness impact profile (SIP): development and final revision of a health status measurement. Med Care 19:787-805
47. Kohlmann T (2000) Das Nottingham Health Profile und das Sickness Impact Profile, Kapitel 11-3. In: Ravens-Sieberer U, Cieza A (Hrsg) Lebensqualität und Gesundheitsökonomie in der Medizin. Ecomed, Landsberg, pp 86-97. Original: Bergner M, Bobbit RA, Carter WB, et al. (1981) The sickness impact profile (SIP): development and final revision of a health status measurement. Med Care 19:787-805
48. Lankhorst GJ, Jelles F, Smits RC et al. (1996) Quality of life in multiple sclerosis: the disability and impact profile (DIP). J Neurol 243(6):469-474
49. Lappin MS, Lawrie FW, Richards TL et al. (2003) Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial. Altern Ther Health Med 9(4):38-48
50. Lintern TC, Beaumont JG, Kenealy PM et al. (2001) Quality of Life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling. Qual Life Res 10(4):371-378
51. Marrie RA, Miller DM, Chelune GJ et al. (2003) Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler 9:621-626
52. Matsumoto J, Morrow D, Kaufman K et al. (2001) Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology 57(10):1876-1882
53. McKeown LP, Porter-Armstrong AR Baxter GD (2003) The needs and experiences of caregivers of individuals with multiple sclerosis: a systematic review. Clin Rehabil 17(3):234-248
54. Merkelbach S, Sittinger H, König J (2002) Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis? J Nerv Ment Dis 190(6):388-393
55. Meyers AR, Gage H, Hendricks A (2000) Health-related quality of life in neurology. Arch Neurol 57(8):1224-1227
56. Miller DM, Rudick RA, Cutter G et al. (2000) Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Arch Neurol 57(9):1319-1324
57. Miller DM, Rudick RA, Baier M et al. (2003) Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 9(1):1-5
58. Murphy N, Confavreux C, Haas J et al. (1998) Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. J Neurol Neurosurg Psychiatry 65:460-466
59. Murrell RC, Kenealy PM, Beaumont JG et al. (1999) Assessing quality of life in persons with severe neurological disability associated with multiple sclerosis: the psychometric evaluation of two quality of life measures. Br J Health Psychol 4:349-362
60. Neudert C, Wasner M, Borasio GD (2001) Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 191:103-109
61. Nicholl CR, Lincoln NB, Francis VM et al. (2001) Assessing quality of life in people with multiple sclerosis. Disabil Rehabil 23(14)597-603
62. Nortvedt MW, Riise T, Myhr KM et al. (1999) Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 53(5):1098-1103
63. Nortvedt MW, Riise T, Myhr KM et al. (1999) Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a. Mult Scler 5(5):317-322
64. Nortvedt MW, Riise T, Myhr KM et al. (2000) Quality of life as a predictor for change in disability in MS. Neurology 55(1):51-54
65. Nortvedt MW, Riise T, Myhr KM et al. (2000) Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care 38(10):1022-1028
66. Nortvedt MW, Riise T, Myhr KM et al. (2001) Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 7(4):231-235
67. Nortvedt MW, Riise T (2003) The use of quality of life measures in multiple sclerosis research. Mult Scler 9(1):63-72
68. O'Connor P, Lee L, Ng PT et al. (2001) Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology 57(5):889-891
69. Parkin D, Jacoby A, McNamee P et al. (2000) Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosurg Psychiatry 68(2):144-149
70. Patten SB, Metz LM (2002) Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis. Int J Psychiatry Med 32(2):155-165
71. Patti F, Cacopardo M, Palermo F et al. (2003) Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. J Neurol Sci 211(1-2):55-62
72. Patti F, Ciancio MR, Reggio E et al. (2002) The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol 249(8):1027-1033
73. Petajan JH, Gappmaier E, White AT et al. (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39(4):432-441
74. Pfennings L, Cohen L, Ader H et al. (1999) Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J Neurol 246(7)587-591
75. Pfennings L, Cohen L, Miller D et al. (1999) Using the Short Form-36 with multiple sclerosis patients in five countries: a cross-cultural comparison. Psychol Rep 85(1):19-31
76. Pozzilli C, Brunetti M, Amicosante AM et al. (2002) Home based management in multiple sclerosis: results of a randomised controlled trial. J Neurol Neurosurg Psychiatry 73(3):250-255
77. Rabins PV, Brooks BR (1981) Emotional disturbance in multiple sclerosis patients: validity of the General Health Questionnaire (GHQ). Psychol Med 11:425-127
78. Rao SM, Leo GJ, Ellington L et al. (1991) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692-696
79. Reynolds F, Prior S (2003) "Sticking jewels in your life": exploring women's strategies for negotiating an acceptable quality of life with multiple sclerosis. Qual Health Res 13(9):1225-1251
80. Riazi A, Hobart JC, Lamping DL et al. (2003) Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler 9:411-419. Test in: Hobart JC, Lamping DL, Fitzpatrick R et al. (2001) The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 124:962-973
81. Riazi A, Hobart JC, Lamping DL et al. (2003) Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler 9:411-419. Test in: Hobart JC, Lamping DL, Fitzpatrick R et al. (2001) The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 124:962-973
82. Rice GP, Oger J, Duquette P et al. (1999) Treatment with interferon beta-1b improves quality of life in multiple sclerosis. Can J Neurol Sci 26(4):276-282
83. Rothwell PM (1998) Quality of life in multiple sclerosis. J Neurol Neurosurg Psychiatry 65:433
84. Rothwell PM, McDowell Z, Wong CK et al. (1997) Doctors and patients don't agree: cross-sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 314:1580-1583
85. Rotstein Z, Barak Y, Noy S et al. (2000) Quality of life in multiple sclerosis: development and validation of the 'RAYS' scale and comparison with the SF-36. Int J Qual Health Care 12(6)511-517
86. Rudick RA, Miller D, Clough JD et al. (1992) Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 49(12):1237-1242
87. Ruta DA, Garratt AM, Leng M et al. (1994) A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care 32:1109-1126
88. Schulenburg von der JM, Claes C, Greiner W et al. (1998) Die deutsche Version des EuroQol-Fragebogens. Z Gesundheitswiss 6:3-20. Original: EuroQoL Group (1990) EuroQoL - a new facility for the measurement of health related quality of life. Health Policy 16:199-208
89. Schulenburg von der JM, Claes C, Greiner W et al. (1998) Die deutsche Version des EuroQol-Fragebogens. Z Gesundheitswiss 6:3-20. Original: EuroQoL Group (1990) EuroQoL - a new facility for the measurement of health related quality of life. Health Policy 16:199-208
90. Schumacher J, Klaiberg A, Brähler E (2003) Diagnostische Verfahren zu Lebensqualität und Wohlbefinden. Hogrefe, Göttingen, pp 9-24
91. Schwartz CE, Brotman S, LaRocca N et al. (1998) Patient's perception of quality of care provided by specialists and generalists. Mult Scler 4(5):426-432
92. Schwartz CE, Coulthard-Morris L, Cole B et al. (1997) The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis. Arch Neurol 54(12):1475-1480
93. Schwartz CE, Vollmer T, Lee H et al. (1999) Reliability and validity of two self-report measures of impairment and disability for MS. Neurology 52:63-70
94. Shawaryn MA, Schiaffino KM, LaRocca NG et al. (2002) Determinants of health-related quality of life in multiple sclerosis: the role of illness intrusiveness. Mult Scler 8(4):310-318
95. Solari A, Filippini G, Gasco P et al. (1999) Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 52:57-62
96. Solari A, Filippini G, Mendozzi L et al. (1999) Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 67(2):158-162
97. Somerset M, Peters TJ, Sharp DJ et al. (2003) Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Qual Life Res 12(1):21-29
98. Somerset M, Sharp D, Campbell R (2002) Multiple sclerosis and quality of life: a qualitative investigation. J Health Serv Res Policy 7(3):151-159
99. Stuifbergen AK, Becker H, Blozis S et al. (2003) A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Arch Phys Med Rehabil 84(4):467-476
100. Svensson B, Gerdle B, Elert J (1994) Endurance training in patients with multiple sclerosis: five case studies. Phys Ther 74:1017-1026
101. Thompson AJ (1998) Multiple sclerosis: rehabiltation measures. Semin Neurol 18:397-403
102. Vermersch P, de Seze J, Delisse B et al. (2002) Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment. Mult Scler 8(5):377-381
103. Vernay D, Gerbaud L, Clavelou P (2001) Qualité de vie et sclerose en plaques. Rev Neurol (Paris) 157(8-9 Pt 2):1139-1142
104. Vickrey BG, Hays RD, Genovese BJ et al. (1997) Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol 50(5)557-569
105. Vickrey BG, Hays RD, Harooni R et al. (1995) A health-related quality of life measure for multiple sclerosis. Qual Life Res 4(3):187-206
106. Voltz R, Bernat J, Borasio GD et al. (eds) (2004) Palliative care in neurology. CNS Series, Oxford University Press, Oxford
107. Wang JL, Reimer MA, Metz LM et al. (2000) Major depression and quality of life in individuals with multiple sclerosis. Int J Psychiatry Med 30(4):309-317
108. Ward N, Winters S (2003) Results of a fatigue management programme in multiple sclerosis. Br J Nurs 12(18):1075-1080
109. WHO World Health Organisation (2003) Definition Lebensqualität unter: http://www.who.int/ evidence/assessment-instruments/qol/ql1.htm. WHOQOL-100:The 100 questionswith response scales. Unter: http://www.who.int/msa/ qol. WHO-QOL Group: The development of the World Health Organization Quality of Life Assessment Instrument. Unter: http://www.who.int/evidence/ assessment-instruments/qol/ql1.htm
110. WHO World Health Organisation (2003) Definition Lebensqualität unter: http://www.who.int/ evidence/assessment-instruments/qol/ql1.htm. WHOQOL-100:The 100 questionswith response scales. Unter: http://www.who.int/msa/ qol. WHO-QOL Group: The development of the World Health Organization Quality of Life Assessment Instrument. Unter: http://www.who.int/evidence/ assessment-instruments/qol/ql1.htm
111. WHO World Health Organisation (2003) Definition Lebensqualität unter: http://www.who.int/ evidence/assessment-instruments/qol/ql1.htm. WHOQOL-100:The 100 questionswith response scales. Unter: http://www.who.int/msa/ qol. WHO-QOL Group: The development of the World Health Organization Quality of Life Assessment Instrument. Unter: http://www.who.int/evidence/ assessment-instruments/qol/ql1.htm
112. Zajicek J, Fox P, Sanders H et al. (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 362(9395):1517-1526
113. Zifko UA, Rupp M, Schwarz S et al. (2002) Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 249(8):983-987
114. Zivadinov R, Zorzon M, Tommasi MA et al. (2003) A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-la. J Neurol Sci 216(1):113-118